investor ligand.com

Investor Summary Ligand Pharmaceuticals, Inc. LGND

Mar 6, 2018. Ligand Licenses Glucagon Receptor Antagonist Program to Roivant Sciences Read more. 2017 - Year End Results. Ended Dec 31, 2017. Sign Up For Email Alerts. Ligand Pharmaceuticals, Inc. 3911 Sorrento Valley Boulevard. San Diego, CA 92121. 330 N Brand Blvd. Glendale, CA 91203. 2018 Ligand Pharmaceuticals, Inc.
traffic

OVERVIEW

This domain investor.ligand.com currently has a traffic ranking of zero (the smaller the more traffic). We have explored six pages within the domain investor.ligand.com and found seven websites referring to investor.ligand.com. We were able to observe one social networking sites linked to this website.
Pages Crawled
6
Links to this site
7
Social Links
1

INVESTOR.LIGAND.COM RANKINGS

This domain investor.ligand.com has seen varying amounts of traffic in the past the year.
Traffic for investor.ligand.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.ligand.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.ligand.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

Ligand Pharmaceuticals, Inc. LGND

Ligand has multiple technologies and unpartnered programs available for out-licensing.

WHAT DOES INVESTOR.LIGAND.COM LOOK LIKE?

Desktop Screenshot of investor.ligand.com Mobile Screenshot of investor.ligand.com Tablet Screenshot of investor.ligand.com

INVESTOR.LIGAND.COM HOST

We identified that the main page on investor.ligand.com took nine hundred and seventy-two milliseconds to stream. We found a SSL certificate, so therefore our web crawlers consider this site secure.
Load time
0.972 secs
SSL
SECURE
Internet Protocol
34.235.255.140

WEBSITE IMAGE

SERVER OS

I discovered that this domain is weilding the Apache server.

PAGE TITLE

Investor Summary Ligand Pharmaceuticals, Inc. LGND

DESCRIPTION

Mar 6, 2018. Ligand Licenses Glucagon Receptor Antagonist Program to Roivant Sciences Read more. 2017 - Year End Results. Ended Dec 31, 2017. Sign Up For Email Alerts. Ligand Pharmaceuticals, Inc. 3911 Sorrento Valley Boulevard. San Diego, CA 92121. 330 N Brand Blvd. Glendale, CA 91203. 2018 Ligand Pharmaceuticals, Inc.

CONTENT

This domain investor.ligand.com had the following on the site, "Ligand Licenses Glucagon Receptor Antagonist Program to Roivant Sciences Read more." We observed that the webpage said " 2017 - Year End Results." It also stated " Ended Dec 31, 2017. Sign Up For Email Alerts. San Diego, CA 92121. 2018 Ligand Pharmaceuticals, Inc."

SEEK MORE DOMAINS

Investors Eli Lilly and Company

Lilly is about more than creating medicines. Responsibility is not a fad. It is at the core of who we are. Our products help shape diabetes care worldwide. More than 7,300 people comprise.

Investor Relations Limoneira

Limoneira CEO Edwards Discusses Produce Business. Museum of Ventura County Agriculture Museum. Santa Paula, California 93060. 2018 Annual Meeting of Stockholders. New York, NY 10017.

Investor Relations Liquidity Services

A Better Future for Surplus. Liquidity Services at a Glance. Liquidity Services Announces Third Quarter 2015 Financial Results. Liquidity Services Chief Information Officer Leoncio Casusol Named to 2015 HITEC 100 Most Influential Hispanics in IT. There are currently no events scheduled.

LKQ Corporation Investor Relations Investor Relations

Paint, Body and Equipment. Sell Your Truck or Truck Parts. Keystone Automotive Operations, Inc.

LoopNet Commercial Real Estate For Sale and Lease

The username or password you entered is incorrect. Remember passwords are case sensitive. If you forgot your password, click to reset it. If you continue to see this message, your account may be locked due to too many failed attempts. Please contact Client Services at 1-888-567-7442. Please enter a valid email address. Passwords must be at least 8 characters. Create a free account to get started.